Calcium Disodium Edetate (\(CaNa_2EDTA\))

Mechanism

Pharmacological Group and Molecular Target

Polydentate chelating agent of divalent and trivalent metals with high coordination affinity.

Detailed Mechanism of Action

Circulating soluble lead competitively inactivates the enzyme aminolevulinate dehydratase (ALAD) and ferrochelatase in bone marrow erythroblasts, blocking heme synthesis and causing microcytic anemia and central neurotoxicity due to the accumulation of delta-aminolevulinic acid. Disodium calcium edetate has a six-point coordination structure that surrounds the circulating free lead and displaces the integrated molecular calcium atom in a coordinate manner because lead has a stability constant for EDTA approximately 10 million times higher than that of calcium. The resulting soluble edetate-lead complex is inert and is passively excreted at the kidney through glomerular filtration without dissociating in the collecting ducts.

Indicators and dose

Specific Clinical Indications

• Treatment of severe acute or chronic lead poisoning (lead poisoning) with blood lead concentrations greater than 45 mcg/dL in children and adults with or without symptoms of encephalopathy.

Dosage Scheme and Infusion Protocols

• Adults and Children with Lead Encephalopathy: 1000 mg to 1500 mg/m²/day administered as a continuous slow intravenous infusion diluted in 500 mL of 5% dextrose solution, or divided into deep intramuscular doses every 12 hours. It should always be associated with Dimercaprol (BAL) starting the first dose of BAL 4 hours before the EDTA infusion, to prevent the rapid displacement of bone lead deposits towards the brain parenchyma.
• Monitoring: Monitor renal function closely (creatinine, daily urine output). Lead edetate is potentially nephrotoxic to proximal tubular cells at high cumulative doses.

Security

Serious Drug Confusion Alert with EDTA Sodium

It is a clinical error with fatal consequences to confuse Calcium Disodium Edetate (CaNa₂EDTA) with Disodium Edetate (Na₂EDTA). Pure edetate disodium that does not contain calcium instantly binds to free serum calcium in the bloodstream, triggering sudden, severe hypocalcemia that causes tetany, cardiac arrest due to QT prolongation, and imminent death. Only edetate containing incorporated calcium (CaNa₂EDTA) should be used as a heavy metal chelating agent in daily medical practice.